2 Nasdaq Stocks Up More Than 100% in the Past 4 Weeks

NASDAQ: WKHS | Workhorse Group, Inc. News, Ratings, and Charts

WKHS – Workhorse Group (WKHS) and Novavax (NVAX) are two Nasdaq stocks that have rallied more than 100% over the past 3 weeks.

When looking for short term stock opportunities, investors should consider recent returns as one way to ride the momentum. Looking at 1-month turns is a perfect example. The S&P 500, represented by the SPDR 500 ETF (SPY) is up 3.5% over the last month as of today’s close. That’s not a bad return, but many stocks have generated massive gains over the same time period.

For this article’s purposes, I decided to look for a minimum of 100% return over the last four weeks. I then narrowed the list for stocks with either a Strong Buy or a Buy in our POWR Ratings system. Here are two stocks that have returned over 100% the past four weeks.

Workhorse Group (WKHS)

WKHS designs, develop, manufactures, and sells high-performance, medium-duty trucks. The company’s products include trucks comprising a powertrain and chassis. WKHS has established a business relationship with United Parcel Service (UPS) and the U.S. Postal Service. The stock is up a whopping 308.47% over the past month. 

The company recently reported certification for its electric delivery trucks. That news sent WKHS up almost 2% for the day. The approval came from the California Air Resources Board (CARB), which means CARB recognizes its electric delivery trucks as zero-emissions vehicles in California. WKHS is now closer to joining the California Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP). When it does, it will be eligible for monetary vouchers. This will reduce the total cost of a vehicle for a customer. 

WKHS expects 557% sales growth next year. The stock is also a Buy in our POWR Ratings. It is ranked #8 out of 27 Auto & Vehicle Manufacturers.

Novavax (NVAX)

NVAX, a late-stage biotechnology company, focuses on discovering, developing, and commercializing vaccines to prevent serious infectious diseases. The company has been in the news due to a promising vaccine for COVID-19 called NVX-CoV2372. If approved, NVAX is talking about manufacturing a billion doses. The stock is up 128.92% year to date.

The company has received financial support from several sources. In May, the Coalition for Epidemic Preparedness Innovations invested $388 million in NVAX’s possible vaccine. The U.S. government also agreed to pay the company $1.6 billion through Operation Warp Speed to help with development.

So far, NVAX’s vaccine produces more antibodies than any other rivals’ possible vaccines, and the vaccine platform has proven superior. Their flu vaccine, NanoFlu, was proven superior to the market leader, Sanofi’s (SNY) Fluzone Quadrivalent, in numerous clinical trials. NVAX, which has a Buy rating in our POWR Rating service, is ranked #33 out of 338 stocks in the Biotech industry. 

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

Top 5 WINNING Stock Chart Patterns

7 “Safe-Haven” Dividend Stocks for Turbulent Times

WKHS shares rose $0.88 (+5.70%) in premarket trading Tuesday. Year-to-date, WKHS has gained 434.54%, versus a -1.40% rise in the benchmark S&P 500 index during the same period.


About the Author: David Cohne

David Cohne has 20 years of experience as an investment analyst and writer. Prior to StockNews, David spent eleven years as a consultant providing outsourced investment research and content to financial services companies, hedge funds, and online publications. David enjoys researching and writing about stocks and the markets. He takes a fundamental quantitative approach in evaluating stocks for readers. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
WKHSGet RatingGet RatingGet Rating
NVAXGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com

Inflation Not Fading Fast Enough for Stock Investors

Investors may have celebrated the end of high inflation too soon. The CPI report shows inflation bouncing higher and thus pushing back the start date for Fed rate cuts. This has the S&P 500 (SPY) coming off recent highs. This begs questions like how much more downside could we see? And when will the bull market get back on track? 44 year investment veteran Steve Reitmeister shares his answers to these questions in this timely commentary including a preview of his top picks to stay ahead of the pack. Read on below for more...

3 Auto Stocks to Consider Over TSLA in April

Tesla (TSLA) reported a decline in deliveries in the first quarter, and Wall Street expects the company to deliver fewer vehicles than last year. Furthermore, rising competition, slowing EV sales, and stretched valuation make TSLA unattractive from an investment standpoint. Considering these factors, investors could consider buying fundamentally strong auto stocks Blue Bird (BLBD), Rolls-Royce Holdings (RYCEY), and Stellantis (STLA) over Tesla (TSLA). Read more...

3 Top-Rated Tech Stock Buys for Value in April

The technology sector is undergoing a notable surge, propelled by increasing digitalization endeavors among businesses and governmental support for technological progress. So, fundamentally sound tech stocks Box Inc. (BOX), Teradata (TDC), and Materialise (MTLS), which seem pretty undervalued, might be ideal buys this month. Continue reading...

Top Software Stocks at the Forefront of Market Gains

The software industry's prospects appear bright due to increasing investments in digital transformation, high demand for advanced software services from various sectors, and the integration of emerging technologies such as generative AI. Therefore, investors could consider buying quality software stocks Autodesk (ADSK), DocuSign (DOCU), and Pegasystems (PEGA) for solid gains. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More Workhorse Group, Inc. (WKHS) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All WKHS News